Consolidated statements of income

(Unit: thousands of yen)

For the fiscal year

ended March 31, 2024

For the fiscal year

ended March 31, 2025

Net sales

52,755,890

58,760,592

Cost of sales

42,418,831

46,980,908

Gross profit

10,337,058

11,779,684

Selling, general and administrative expenses

Advertising expenses

127,168

157,448

Remuneration, salaries and allowances for directors (and other officers)

2,155,745

2,219,409

Bonuses

167,441

187,963

Provision for bonuses

212,572

223,479

Provision for bonuses for directors (and other officers)

57,642

59,058

Retirement benefit expenses

61,443

51,540

Provision for retirement benefits for directors (and other officers)

-

680

Legal welfare expenses

346,218

362,760

Hiring expenses

192,381

228,722

Education expense

169,921

131,802

Entertainment expenses

67,473

85,479

Rent expenses on land and buildings

186,914

226,610

Supplies expenses

81,893

86,737

Amortization of goodwill

210,697

344,322

Enterprise tax

223,659

227,231

Other

954,107

1,202,615

Total selling, general and administrative expenses

5,215,282

5,795,861

Operating profit

5,121,775

5,983,822

Non-operating income

Interest income

250,725

233,905

Dividend income

65,686

79,189

Gain on sales of securities

20,942

18,062

Gain on investments in money held in trust

30,939

3,964

Gain on valuation of derivatives

273,440

30,103

Subsidy income

40,779

51,367

Share of profit of entities accounted for using equity method

52,107

62,812

Other

29,772

31,192

Total non-operating income

764,393

510,597

Non-operating expenses

Interest expenses

2,687

11,243

Loss on valuation of securities

3,887

25,436

Investment advisory fee

90,385

131,692

Donations

121,000

12,000

Other

9,673

23,406

Total non-operating expenses

227,633

203,778

Ordinary profit

5,658,535

6,290,640

Extraordinary income

Gain on sale of non-current assets

-

983

Gain on sale of investment securities

323,351

173,288

Gain on redemption of investment securities

108,001

57,315

Gain on sale of shares of subsidiaries and associates

-

1,626

Surrender value of insurance policies

12,193

11,599

Other

-

3,197

Total extraordinary income

443,545

248,010

Extraordinary losses

Loss on retirement of non-current assets

10,809

16,663

Loss on sale of investment securities

776

5,380

Loss on valuation of investment securities

5,807

23,209

Office relocation expenses

3,838

42,008

Impairment losses

296,694

89,459

Loss on compensations

-

85,475

Other

83,845

33,199

Total extraordinary losses

401,772

295,397

Profit before income taxes

5,700,308

6,243,253

Income taxes - current

2,035,570

1,924,200

Income taxes - deferred

-63,843

-86,514

Total income taxes

1,971,727

1,837,686

Profit

3,728,580

4,405,567

Profit attributable to non-controlling interests

-

-

Profit attributable to owners of parent

3,728,580

4,405,567

(Unit: yen)

FY2023

End of consolidated accounting period

(As of March 31, 2024)

FY2024

End of consolidated accounting period

(As of March 31, 2025)

Research and development costs

83,143,917

86,886,470

Consolidated statements of comprehensive income

(Unit: thousands of yen)

For the fiscal year

ended March 31, 2024

For the fiscal year

ended March 31, 2025

Profit

3,728,580

4,405,567

Other comprehensive income

Valuation difference on available-for-sale securities

1,431,425

65,851

Foreign currency translation adjustment

8,537

-5,735

Remeasurements of defined benefit plans, net of tax

85,959

-46,394

Total other comprehensive income

1,525,923

13,721

Comprehensive income

5,254,504

4,419,289

Comprehensive income attributable to

Comprehensive income attributable to owners of parent

5,254,504

4,419,289

Comprehensive income attributable to non-controlling interests

-

-

Please note the following:
・The data used within this site is compiled from the corporate prospectus and earnings announcements.
・This site may not be immediately rectified as correction of earnings data and others.

Download Key Financial Data